Following teens and adults with atopic dermatitis as they start or change systemic treatment
Follows adolescents and adults with atopic dermatitis starting or switching systemic treatments.
Plain-language title generated from the registry record
Registry title: This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Key facts
- Where
- Albuquerque, Ann Arbor, Auburn Hills, Bakersfield, Bay City, Birmingham, Bolivar, Bountiful, Caledonia, Dallas, Detroit, Doral, Falls Church, Fargo, Fort Worth, Fremont, Gilbert, Huntersville, Kirksville, Las Vegas, Lincoln, Los Angeles, Macon, Marion, Mason, Mill Creek, Montgomery, Normal, North Chicago, North Miami Beach, Northridge, Oakland, Pflugerville, Phoenix, Pittsburgh, Pomona, Portsmouth, San Diego, Seattle, Spartanburg, Springville, Sugar Land, Warwick, Waterford, Wheat Ridge, and Winston-Salem, United StatesSee the 46 sites
Where in United States
- University Of New Mexico School Of Medicine- Site Number : 8400022Albuquerque, United StatesTaking people
- David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017Ann Arbor, United StatesTaking people
- Auburn HillsAuburn Hills, United StatesTaking people
- Kern Research, Inc.- Site Number : 8400047Bakersfield, United StatesTaking people
- Great Lakes Research Group - Bay City- Site Number : 8400052Bay City, United StatesTaking people
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006Birmingham, United StatesTaking people
- Red River Research Partners, Llc- Site Number : 8400054Bolivar, United StatesTaking people
- Cope Family Medicine - Ogden Clinic- Site Number : 8400053Bountiful, United StatesTaking people
- The Derm Institute of West Michigan- Site Number : 8400025Caledonia, United StatesTaking people
- Reveal Research Institute - Dallas- Site Number : 8400012Dallas, United StatesTaking people
- Wayne State University - Detroit Medical Center- Site Number : 8400035Detroit, United StatesTaking people
- DoralDoral, United StatesTaking people
- Falls ChurchFalls Church, United StatesTaking people
- Red River Research Partners - Fargo- Site Number : 8400037Fargo, United StatesTaking people
- Innovate Research - Fort Worth- Site Number : 8400016Fort Worth, United StatesNo longer taking part
- Center for Dermatology Clinical Research- Site Number : 8400014Fremont, United StatesTaking people
- San Tan Allergy & Asthma- Site Number : 8400031Gilbert, United StatesTaking people
- Piedmont Plastic Surgery and Dermatology- Site Number : 8400038Huntersville, United StatesTaking people
- KirksvilleKirksville, United StatesTaking people
- Las VegasLas Vegas, United StatesTaking people
- Allergy Asthma & Immunology- Site Number : 8400044Lincoln, United StatesTaking people
- Dermatology Research Associates - Los Angeles- Site Number : 8400020Los Angeles, United StatesTaking people
- Skin Care Physicians of Georgia - Macon- Site Number : 8400034Macon, United StatesTaking people
- Dermatology Associates of Mid-Ohio- Site Number : 8400026Marion, United StatesTaking people
- Dermatologists of Southwest Ohio - Mason- Site Number : 8400050Mason, United StatesTaking people
- Frontier Dermatology Partners CRO LLC- Site Number : 8400011Mill Creek, United StatesTaking people
- River Region Dermatology and Laser- Site Number : 8400041Montgomery, United StatesTaking people
- Sneeze, Wheeze, & Itch Associates, LLC- Site Number : 8400029Normal, United StatesTaking people
- Rosalind Franklin University of Medicine and Science- Site Number: 8400056North Chicago, United StatesTaking people
- Ziaderm Research, LLC- Site Number : 8400021North Miami Beach, United StatesTaking people
- Northridge Clinical Trials, LLC- Site Number : 8400009Northridge, United StatesTaking people
- Sunwise Clinical Research, LLC.- Site Number : 8400010Oakland, United StatesTaking people
- Austin Institute for Clinical Research, Inc- Site Number : 8400030Pflugerville, United StatesTaking people
- PhoenixPhoenix, United StatesTaking people
- UPMC - Department of Dermatology- Site Number : 8400024Pittsburgh, United StatesTaking people
- Empire Clinical Research, LLC- Site Number : 8400007Pomona, United StatesTaking people
- PortsmouthPortsmouth, United StatesTaking people
- University Clinical Trials- Site Number : 8400019San Diego, United StatesTaking people
- University of Washington - Roosevelt Location- Site Number : 8400005Seattle, United StatesTaking people
- Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004Spartanburg, United StatesTaking people
- Springville Dermatology - Springville- Site Number : 8400055Springville, United StatesTaking people
- Complete Dermatology - Sugar Land- Site Number : 8400001Sugar Land, United StatesTaking people
- Care Access Research - Warwick 2- Site Number : 8400045Warwick, United StatesTaking people
- Michigan Dermatology Institute - Waterford- Site Number : 8400013Waterford, United StatesTaking people
- Western States Clinical Research, Inc.- Site Number : 8400051Wheat Ridge, United StatesTaking people
- Wake Forest University Health Sciences- Site Number : 8400003Winston-Salem, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sanofi
- Trial code
- NCT07290803
- Record updated
- 2 November 2026
- Original description
The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. Additionally, patient-specific factors (such as age, skin color, AD flare triggers, previous treatment responses, comorbid conditions, and the extent and site of lesions) will be assessed to better characterize the impact on the treatment journey across a broad age range and diverse geographic regions.Read full original descriptionShow less
Atopic Dermatitis Disease Registry of Adult and Adolescent Patients Initiating or Switching Systemic Treatments
The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. Additionally, patient-specific factors (such as age, skin color, AD flare triggers, previous treatment responses, comorbid conditions, and the extent and site of lesions) will be assessed to better characterize the impact on the treatment journey across a broad age range and diverse geographic regions.
The study will be conducted across 10 countries in 4 different geographical regions, with a follow-up period of 5 years.
Inclusion: Patients aged more than or equal to (≥) 12 years at the time of consent; Confirmed diagnosis of AD, of any severity, according to the Investigator's assessment as aligned with International Classification of Diseases 10th revision (ICD-10) code of L20; Prescribed and scheduled to initiate any systemic treatment for AD (including but not limited to biologics, oral Janus kinase (JAK) inhibitors, cyclosporine, azathioprine, methotrexate, mycophenolate mofetil); Signed informed consent for registry participation by the patient or parent/legal representative and assent by the patient appropriate to the patient's age, including willingness to participate in long-term follow-up.
Exclusion: Concurrent participation in an interventional clinical trial that administers an investigational drug that modifies patient care; Insufficient understanding of the study by the patient and/or parent/guardian; The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.